Request for ONC to Update GuidanceIm recommending shareholders message ONC on their website requesting update on Breast Cancer upcoming milestones. The typee C meeting concluded and they have not updated guidance.
1. When do rhey expect to file for approval of the phase 3 breast cancer trial?
2. Are they awaiting additional data or conclusion of the Bracelet trial before doing so?
3. When do they expect first enrollment in the phase?
4. What is the target population for the therapeutic? What does including upto first ADC treatment mean? Are they expecting to be the frontline treatment of choice?
To message go to oncolytic biotechs website and under contact they give opportunity for inquiry.